The Allstate Corporation
The Allstate Corporation (ALL-PH) Financial Performance & Income Statement Overview
Review The Allstate Corporation (ALL-PH) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
The Allstate Corporation (ALL-PH) Income Statement & Financial Overview
Review The Allstate Corporation ALL-PH income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $16.46B | $16.50B | $16.64B | $15.73B |
| Cost of Revenue | $13.23B | $11.42B | $12.76B | $13.09B |
| Gross Profit | $3.22B | $5.08B | $3.87B | $2.63B |
| Gross Profit Ratio | $0.20 | $0.31 | $0.23 | $0.17 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $78.00M | -$52.00M | $26.00M | -$9.00M |
| Operating Expenses | $2.50B | $2.63B | $2.45B | $2.20B |
| Total Costs & Expenses | $15.74B | $14.05B | $15.22B | $15.30B |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $100.00M | $101.00M | $104.00M | $98.00M |
| Depreciation & Amortization | $132.00M | $151.00M | $140.00M | $132.00M |
| EBITDA | $951.00M | $2.70B | $1.66B | $660.00M |
| EBITDA Ratio | $0.06 | $0.16 | $0.10 | $0.04 |
| Operating Income | $819.00M | $2.55B | $1.52B | $528.00M |
| Operating Income Ratio | $0.05 | $0.15 | $0.09 | $0.03 |
| Other Income/Expenses (Net) | $0.00 | $0.00 | $0.00 | $0.00 |
| Income Before Tax | $719.00M | $2.45B | $1.42B | $430.00M |
| Income Before Tax Ratio | $0.04 | $0.15 | $0.09 | $0.03 |
| Income Tax Expense | $123.00M | $559.00M | $254.00M | $83.00M |
| Net Income | $595.00M | $1.93B | $1.19B | $331.00M |
| Net Income Ratio | $0.04 | $0.12 | $0.07 | $0.02 |
| EPS | $2.14 | $7.16 | $4.39 | $1.14 |
| Diluted EPS | $2.11 | $7.07 | $4.33 | $1.13 |
| Weighted Avg Shares Outstanding | $264.30M | $265.10M | $264.60M | $264.10M |
| Weighted Avg Shares Outstanding (Diluted) | $267.80M | $268.70M | $268.00M | $267.10M |
The company's financials show resilient growth, with revenue advancing from $15.73B in Q2 2024 to $16.46B in Q1 2025. Gross profit remained healthy with margins at 20% in Q1 2025 compared to 17% in Q2 2024. Operating income hit $819.00M last quarter, sustaining a consistent 5% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $951.00M. Net income dropped to $595.00M, while earnings per share reached $2.14. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan